Benevolent AI (Benevolent AI) EBITDA Margin % : -1,348.19% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Benevolent AI's EBITDA for the three months ended in Dec. 2023 was $-34.72 Mil. Benevolent AI's Revenue for the three months ended in Dec. 2023 was $2.58 Mil. Therefore, Benevolent AI's EBITDA margin for the quarter that ended in Dec. 2023 was -1,348.19%.

Benevolent AI EBITDA Margin % Historical Data

The historical data trend for Benevolent AI's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI EBITDA Margin % Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

-1,178.68

-900.45

-2,558.44

-1,670.30

-947.24

Benevolent AI Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial				-2,475.65	-3,038.10	-511.69	-793.26	-1,348.19

Competitive Comparison of Benevolent AI's EBITDA Margin %

For the Biotechnology subindustry, Benevolent AI's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benevolent AI's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Benevolent AI's EBITDA Margin % falls into.

Benevolent AI EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Benevolent AI's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-87.904	/	9.28
	=	-947.24 %

Benevolent AI's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-34.716	/	2.575
	=	-1,348.19 %

Benevolent AI (GREY:BAIVF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Benevolent AI EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Benevolent AI's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Benevolent AI (Benevolent AI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

BAI:Netherlands 2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.